References
1. Luo GG & Gao SJ (2020) Global health concerns stirred by emerging viral infections. J Med Virol 92(4):399-400.
2. Chen Y, Liu Q, & Guo D (2020) Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol92(4):418-423.
3. Shang J, et al. (2020) Cell entry mechanisms of SARS-CoV-2.Proc Natl Acad Sci U S A 117(21):11727-11734.
4. Jackson CB, Farzan M, Chen B, & Choe H (2022) Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23(1):3-20.
5. Hoffmann M, et al. (2020) SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181(2):271-280 e278.
6. V’Kovski P, Kratzel A, Steiner S, Stalder H, & Thiel V (2021) Coronavirus biology and replication: implications for SARS-CoV-2.Nat Rev Microbiol 19(3):155-170.
7. Vandenberg O, Martiny D, Rochas O, van Belkum A, & Kozlakidis Z (2021) Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol 19(3):171-183.
8. Case JB, Bailey AL, Kim AS, Chen RE, & Diamond MS (2020) Growth, detection, quantification, and inactivation of SARS-CoV-2.Virology 548:39-48.
9. Bullen CK, Davis SL, & Looney MM (2022) Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay. Methods Mol Biol 2452:131-146.
10. Arthur JM, et al. (2021) Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One 16(9):e0257016.
11. Frolova EI, et al. (2022) Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling. J Virol 96(15):e0075322.